These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6663653)

  • 1. The metabolism of platelet activating factor in platelets and plasma of various animals.
    Yamashita M; Homma H; Inoue K; Nojima S
    J Toxicol Sci; 1983 Aug; 8(3):177-88. PubMed ID: 6663653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The binding of rabbit basophil-derived platelet-activating factor to rabbit platelets.
    Shaw JO; Henson PM
    Am J Pathol; 1980 Mar; 98(3):791-810. PubMed ID: 6987890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolism of 1-acyl-PAF in rabbit platelets and its possible interaction with PAF.
    Touqui L; Silva CS; Vargaftig BB
    Lipids; 1991 Dec; 26(12):992-6. PubMed ID: 1819755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translocation of exogenous platelet-activating factor and its lyso-compound through plasma membranes is a rate-limiting step for their metabolic conversions into alkylacylglycerophosphocholines in rabbit platelets and guinea-pig leukocytes.
    Tokumura A; Tsutsumi T; Yoshida J; Tsukatani H
    Biochim Biophys Acta; 1990 May; 1044(1):91-100. PubMed ID: 2340312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible influence of lysophospholipase on the production of 1-acyl-2-acetylglycerophosphocholine in macrophages.
    Nakagawa Y; Sugai M; Karasawa K; Tokumura A; Tsukatani H; Setaka M; Nojima S
    Biochim Biophys Acta; 1992 Jun; 1126(3):277-85. PubMed ID: 1637856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet.
    Terashita Z; Imura Y; Nishikawa K
    Biochem Pharmacol; 1985 May; 34(9):1491-5. PubMed ID: 2986648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catabolism of platelet-activating factor and its acyl analog. Differentiation of the activities of lysophospholipase and platelet-activating-factor acetylhydrolase.
    Aarsman AJ; Neys FW; Van den Bosch H
    Eur J Biochem; 1991 Aug; 200(1):187-93. PubMed ID: 1879423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505.
    Pons F; Rossi AG; Norman KE; Williams TJ; Nourshargh S
    Br J Pharmacol; 1993 May; 109(1):234-42. PubMed ID: 8495241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific receptor sites for 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes.
    Hwang SB; Lee CS; Cheah MJ; Shen TY
    Biochemistry; 1983 Sep; 22(20):4756-63. PubMed ID: 6313047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposing effects of platelet-activating factor and lyso-platelet-activating factor on neutrophil and platelet activation.
    Welch EJ; Naikawadi RP; Li Z; Lin P; Ishii S; Shimizu T; Tiruppathi C; Du X; Subbaiah PV; Ye RD
    Mol Pharmacol; 2009 Jan; 75(1):227-34. PubMed ID: 18931035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of inhibitors of platelet aggregation on the metabolism of platelet-activating factor (PAF) in washed rabbit platelets.
    O'Neill C; Ammit AJ; Korth R; Fleming S; Wells X
    Lipids; 1991 Dec; 26(12):1011-4. PubMed ID: 1726442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin inhibits platelet-activating factor (PAF)-induced responses in platelets and macrophages: implications for the biologically active form of PAF.
    Grigoriadis G; Stewart AG
    Br J Pharmacol; 1992 Sep; 107(1):73-7. PubMed ID: 1330167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Binding of 1-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (thrombocyte activating factor) by plasma components. Exchange of the thrombocyte activating factor between lipoproteins and thrombocytes].
    Kulikov VI; Bergel'son LD
    Biokhimiia; 1984 Aug; 49(8):1310-5. PubMed ID: 6093897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photoaffinity labeling of platelet activating factor binding sites in rabbit platelet membranes.
    Chau LY; Tsai YM; Cheng JR
    Biochem Biophys Res Commun; 1989 Jun; 161(3):1070-6. PubMed ID: 2545193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of platelet-activating factor by human blood platelets and leucocytes. Evidence against selective utilization of cellular ether-linked phospholipids.
    Sturk A; Schaap MC; Prins A; ten Cate JW; van den Bosch H
    Biochim Biophys Acta; 1989 Dec; 993(2-3):148-56. PubMed ID: 2512985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CIS-19, a novel platelet activating factor receptor antagonist: in vitro and in vivo studies.
    Ko FN; Yu SM; Chen IS; Ishii H; Chang YL; Huang TF; Teng CM
    Biochim Biophys Acta; 1993 Jan; 1175(2):225-31. PubMed ID: 8380343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists.
    Domingo MT; Piro F; Broquet C; Auclair E; Chabrier PE; Braquet P
    Lipids; 1992 Aug; 27(8):582-6. PubMed ID: 1328798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of the binding of platelet-activating factor to platelets of different animal species.
    Iñarrea P; Gomez-Cambronero J; Nieto M; Crespo MS
    Eur J Pharmacol; 1984 Oct; 105(3-4):309-15. PubMed ID: 6510472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist.
    Yamada T; Saito M; Mase T; Hara H; Nagaoka H; Murase K; Tomioka K
    Lipids; 1991 Dec; 26(12):1179-83. PubMed ID: 1668114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
    Grigoriadis G; Stewart AG
    Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.